Clinical implications of the detection of circulating tumor cells in breast cancer patients

被引:2
作者
Banys, Malgorzata [1 ,2 ]
Hartkopf, Andreas D. [1 ]
Krawczyk, Natalia [1 ]
Becker, Sven [1 ]
Fehm, Tanja
机构
[1] Univ Tubingen, Dept Obstet & Gynecol, D-72076 Tubingen, Germany
[2] Marienkronkenhous Hamburg, Dept Obstet & Gynecol, D-22087 Hamburg, Germany
关键词
biomarker; breast cancer; circulating tumor cell; disseminated tumor cell; prognosis; RNA-POSITIVE CELLS; POLYMERASE-CHAIN-REACTION; TIME RT-PCR; PERIPHERAL-BLOOD; BONE-MARROW; PROGNOSTIC-SIGNIFICANCE; MOLECULAR-DETECTION; SYSTEMIC THERAPY; HER2; STATUS; CYTOKERATIN-19;
D O I
10.2217/BMM.11.106
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The detection of disseminated tumor cells in bone marrow is a common phenomenon seen in 30-40% of primary breast cancer patients. The presence of disseminated tumor cells at diagnosis as well as the persistence of disseminated tumor cells is strongly associated with poor clinical outcome. Since bone marrow biopsies are not well tolerated by many patients, the evaluation of circulating tumor cells in the blood might become a desired alternative. Circulating tumor cells are routinely detected, depending on stage of the disease and methodology, in 10-80% of breast cancer patients. Recent studies have shown a prognostic potential of circulating tumor cells in both primary and metastatic settings. The evaluation of circulating tumor cells may become one of the crucial markers for prediction of survival and therapy monitoring, and its characterization might enable specific targeting of minimal residual, and metastatic disease.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 63 条
[51]  
Rack B, 2010, 33 ANN SAN ANT BREAS
[52]  
Rack BK, 2010, CLIN SCI S CIRC TUM
[53]   Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients [J].
Rack, Brigitte ;
Jueckstock, Julia ;
Guenthner-Biller, Maria ;
Andergassen, Ulrich ;
Neugebauer, Julia ;
Hepp, Philip ;
Schoberth, Alexandra ;
Mayr, Doris ;
Zwingers, Thomas ;
Schindlbeck, Christian ;
Friese, Klaus ;
Janni, Wolfgang .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (02) :485-492
[54]   Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437 [J].
Reinholz, Monica M. ;
Kitzmann, Kathleen A. ;
Tenner, Kathleen ;
Hillman, David ;
Dueck, Amylou C. ;
Hobday, Timothy J. ;
Northfelt, Donald W. ;
Moreno-Aspitia, Alvaro ;
Roy, Vivek ;
LaPlant, Betsy ;
Allred, Jake B. ;
Stella, Philip J. ;
Lingle, Wilma L. ;
Perez, Edith A. .
CLINICAL CANCER RESEARCH, 2011, 17 (22) :7183-7193
[55]   Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial [J].
Riethdorf, Sabine ;
Mueller, Volkmar ;
Zhang, Liling ;
Rau, Thomas ;
Loibl, Sibylle ;
Komor, Martina ;
Roller, Marc ;
Huober, Jens ;
Fehm, Tanja ;
Schrader, Iris ;
Hilfrich, Joern ;
Holms, Frank ;
Tesch, Hans ;
Eidtmann, Holger ;
Untch, Michael ;
von Minckwitz, Gunter ;
Pantel, Klaus .
CLINICAL CANCER RESEARCH, 2010, 16 (09) :2634-2645
[56]   The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19 [J].
Schoenfeld, A ;
Kruger, KH ;
Gomm, J ;
Sinnett, HD ;
Gazet, JC ;
Sacks, N ;
Bender, HG ;
Luqmani, Y ;
Coombes, RC .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (06) :854-861
[57]   American Cancer Society guidelines for the early detection of cancer, 2005 [J].
Smith, RA ;
Cokkinides, V ;
Eyre, HJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :31-44
[58]   Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients [J].
Solomayer, Erich F. ;
Becker, Sven ;
Pergola-Becker, Graziella ;
Bachmann, Robert ;
Kraemer, Bernhard ;
Vogel, Ulrich ;
Neubauer, Hans ;
Wallwiener, Diethelm ;
Huober, Jens ;
Fehm, Tanja N. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 98 (02) :179-184
[59]  
Stathopoulou A, 2003, ANTICANCER RES, V23, P1883
[60]   Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance [J].
Stathopoulou, A ;
Vlachonikolis, I ;
Mavroudis, D ;
Perraki, M ;
Kouroussis, C ;
Apostolaki, S ;
Malamos, N ;
Kakolyris, S ;
Kotsakis, A ;
Xenidis, N ;
Reppa, D ;
Georgoulias, V .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) :3404-3412